Clinical Trials Directory

Trials / Unknown

UnknownNCT03947645

Intensive Neurorehabilitation and Stimulation in Chronic Stroke Patients

Intensive Neurorehabilitation and Stimulation in Chronic Stroke Patients With Severe Motor Impairment of the Upper Extremity

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
University Hospital Tuebingen · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Chronic stroke patients (\> 6 months) with severe motor impairment of the upper extremity will be enrolled in this single-centre, randomized controlled clinical trial (RCT). All patients will take part in two blocks of high-intense motor training with concurrent neuromuscular stimulation of the paretic upper extremity. In a randomized, cross-over block design, patients will receive transcranial stimulation of either the ipsi- or contralesional hemisphere.

Detailed description

Chronic stroke patients (\> 6 months) with severe motor impairment of the upper extremity and non-proportional recovery will be enrolled in this single-centre, randomized controlled clinical trial (RCT). All patients will take part in two blocks of high-intense motor training with concurrent neuromuscular stimulation of the paretic upper extremity. In a randomized, cross-over block design, patients will receive transcranial stimulation of either the ipsi- or contralesional hemisphere. The primary outcome measure is the Fugl-Meyer Assessment for upper extremity (FM-UE), acquired at baseline, after the intervention period, and at 3 months follow-up. Secondary outcome measures consist of further clinical parameters and biomarkers of corticospinal connectivity.

Conditions

Interventions

TypeNameDescription
DEVICEIpsilesional stimulationDevice: ipsilesional transcranial stimulation, neuromuscular Stimulation over target muscle
DEVICEContralesional stimulationDevice: contralesional transcranial stimulation, neuromuscular stimulation over target muscle

Timeline

Start date
2019-05-02
Primary completion
2022-02-01
Completion
2022-12-01
First posted
2019-05-13
Last updated
2021-09-29

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT03947645. Inclusion in this directory is not an endorsement.